Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Total Current Liabilities (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Total Current Liabilities for 6 consecutive years, with $44.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities changed N/A year-over-year to $44.2 million, compared with a TTM value of $44.2 million through Sep 2025, changed N/A, and an annual FY2024 reading of $37.3 million, changed N/A over the prior year.
  • Total Current Liabilities was $44.2 million for Q3 2025 at Viemed Healthcare, up from $37.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $44.2 million in Q3 2025 and bottomed at $17.7 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $26.6 million, with a median of $22.6 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities crashed 42.34% in 2021, then soared 76.8% in 2023.
  • Year by year, Total Current Liabilities stood at $17.8 million in 2021, then grew by 5.9% to $18.9 million in 2022, then skyrocketed by 67.29% to $31.6 million in 2023, then rose by 18.3% to $37.3 million in 2024, then grew by 18.39% to $44.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for VMD at $44.2 million in Q3 2025, $37.3 million in Q2 2025, and $35.5 million in Q1 2025.